Our Executive Clinical Pharmacy talk through the basics of limited distribution drugs and how they affect the marketplace in terms of market access, payer reimbursement, patient care, and drug development.
Topics included in this episode:
Overview and Basic Definitions of Limited Distribution Drugs and their Networks
Pharmacy Motivations for Carrying LDDs
Independent Retail Pharmacies
Hospital Perspectives for Providing LDDs
Payer Implications for Reimbursing for LDDs
Patient Implications for Receiving LDDs
Manufacturer Motivations for Developing LDDs
IPD'S DRUG & CLINICAL REVIEW:
LIMITED DISTRIBUTION DRUGS
"So, we all know that specialty medications can be complex, require special handling, are very costly, can be limited to certain patient types, and have various administration needs. A limited distribution drug network can provide greater scrutiny for all of these things, as well as the ability of adding even more infrastructure to support a single drug. Some of the things that limited distribution drug networks can handle are additional clinical services (and this can include drug administration, drug dispensing, and nursing services), ensuring that the REMS programs requirements for higher-risk drugs are met, helping to decrease waste of these expensive medications, and providing additional patient education.
Another thing that a limited distribution drug network can do is strictly adhere to the special storage and handling needs that these medications require. They also typically have a better understanding of the disease state and the patient's needs. They can provide better service knowing much more about the disease state, the medication’s uses and effects, and in addition, limited distribution drug networks can provide data and reporting consolidation to payers and providers. Some of this data includes outcomes, results, side effects, and adverse effects — all of which can potentially improve utilization of the drug and the experience for the patient."